Abstract | ETHNOPHARMACOLOGICAL RELEVANCE: AIM OF THE STUDY: We previously found that single and multiple doses of XQLT administered to sensitized mice before allergen challenge resulted in suppressed airway hyper-responsiveness and airway inflammation. In this study we aimed to investigate whether XQLT has the potential to attenuate the severity of asthma symptoms, and immunomodulatory mechanism of XQLT in a repetitive Dermatogoides pteronyssinus (D. pteronyssinus)-challenged chronic asthmatic mice model. MATERIALS AND METHODS: BALB/c mice were intratracheally (i.t.) inoculated with five doses of D. pteronyssinus (50 μl, 1mg/ml) and orally administered of XQLT (1 g/kg) at 1-week intervals. At three days after the last challenge, mice were sacrificed to evaluate airway remodeling, inflammation, lung histological features, and the expression profiles of cytokines and various genes. RESULTS: XQLT significantly reduced bronchial inflammatory cell infiltration and airway remodeling. It inhibited D. pteronyssinus-induced total IgE and D. pteronyssinus-specific IgG1 in serum, and changed the "T(H)2-bios" in BALF by inhibiting the activation of NF-κB. Collagen assay and Histopathology indicated that XQLT reduced airway remodeling in the lung. Simultaneously, the RT-PCR analysis showed that XQLT downregulated IL-10, IL-13, RANTES, Eotaxin, and MCP-1 mRNA expression in the lung. Moreover, EMSA and immunohistochemistry staining demonstrated that XQLT inhibited NF-κB expression in the nucleus of bronchial epithelial cells. CONCLUSIONS: These results suggest that XQLT exhibits anti-airway inflammatory, anti- airway remodeling, and specific immunoregulatory effects in a chronic asthmatic mice model.
|
Authors | Shulhn-Der Wang, Li-Jen Lin, Chih-Lung Chen, Shih-Chang Lee, Chin-Che Lin, Jiu-Yao Wang, Shung-Te Kao |
Journal | Journal of ethnopharmacology
(J Ethnopharmacol)
Vol. 142
Issue 2
Pg. 531-8
(Jul 13 2012)
ISSN: 1872-7573 [Electronic] Ireland |
PMID | 22658987
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2012 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Anti-Asthmatic Agents
- Chemokine CCL5
- Chemokines, CC
- Drugs, Chinese Herbal
- Immunoglobulin G
- Interleukin-13
- NF-kappa B
- sho-seiryu-to
- Interleukin-10
- Immunoglobulin E
|
Topics |
- Airway Remodeling
(drug effects)
- Animals
- Anti-Asthmatic Agents
(pharmacology, therapeutic use)
- Asthma
(drug therapy, immunology, metabolism, pathology)
- Bronchial Hyperreactivity
(drug therapy, immunology, metabolism)
- Cell Nucleus
(metabolism)
- Chemokine CCL5
(metabolism)
- Chemokines, CC
(metabolism)
- Chronic Disease
- Disease Models, Animal
- Down-Regulation
- Drugs, Chinese Herbal
(pharmacology, therapeutic use)
- Epithelial Cells
(metabolism)
- Immunoglobulin E
(blood)
- Immunoglobulin G
(blood)
- Inflammation
(drug therapy, metabolism)
- Interleukin-10
(metabolism)
- Interleukin-13
(metabolism)
- Lung
(drug effects, immunology, metabolism, pathology)
- Male
- Mice
- Mice, Inbred BALB C
- NF-kappa B
(metabolism)
- Phytotherapy
- Pyroglyphidae
|